ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AstraZeneca Divests Arimidex, Casodex Rights to Juvisé Pharmaceuticals
December 23, 2019AstraZeneca has agreed to sell the commercial rights to Arimidex (anastrozole) and Casodex (bicalutamide) in a number of European, African and other countries to Juvisé Pharmaceuticals. -
AstraZeneca sells Arimidex and Casodex rights for $181m
December 23, 2019AstraZeneca has divested the commercial rights to Arimidex (anastrozole) and Casodex (bicalutamide) to French pharmaceutical company Juvisé Pharmaceuticals for an upfront payment of $181m.
Pharma Sources Insight January 2025
